killerFLIP: a novel lytic peptide specifically inducing cancer cell death

One of the objectives in the development of effective cancer therapy is induction of tumor-selective cell death. Toward this end, we have identified a small peptide that, when introduced into cells via a TAT cell-delivery system, shows a remarkably potent cytoxicity in a variety of cancer cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales: Pennarun, B, Gaidos, G, Bucur, O, Tinari, A, Rupasinghe, C, Jin, T, Dewar, R, Song, K, Santos, M T, Malorni, W, Mierke, D, Khosravi-Far, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920952/
https://www.ncbi.nlm.nih.gov/pubmed/24176852
http://dx.doi.org/10.1038/cddis.2013.401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920952/
https://www.ncbi.nlm.nih.gov/pubmed/24176852
http://dx.doi.org/10.1038/cddis.2013.401

Ejemplares similares